Innoviva, Inc. (INVA)
NASDAQ·Healthcare·Biotechnology
$20.49
-2.38%
Mkt Cap $1.54B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
Implied Upside
+80.6%
Consensus $37.00 vs current $20.49
NASDAQ·Healthcare·Biotechnology
$20.49
-2.38%
Mkt Cap $1.54B
Buy
5
Hold
0
Sell
0
Price Target (9 analysts)
$37.00
Range $32.00 – $42.00
+80.6%
Consensus $37.00 vs current $20.49